Abstract:
PURPOSE: Provided is a manufacture of bovine and porcine plasma protein powders by treating low dose of gamma-ray, thereby preventing contamination by microorganisms, and removing biological risk factors while maintaining physicochemical properties of the plasma protein. CONSTITUTION: A manufacture of bovine and porcine plasma protein powders comprises the steps of: separating plasma from bovine and porcine using a centrifuger; precipitating the plasma using 2-10% trichloroacetic acid, 0.6-3N of hydrochloric acid, 50-70% of ammonium sulfate and the like; drying the precipitated plasma to give powder thereof; and packing the powder with polyethylene packing material and treating gamma-ray.
Abstract:
PURPOSE: Provided is a manufacture of bovine and porcine plasma protein powders by treating low dose of gamma-ray, thereby preventing contamination by microorganisms, and removing biological risk factors while maintaining physicochemical properties of the plasma protein. CONSTITUTION: A manufacture of bovine and porcine plasma protein powders comprises the steps of: separating plasma from bovine and porcine using a centrifuger; precipitating the plasma using 2-10% trichloroacetic acid, 0.6-3N of hydrochloric acid, 50-70% of ammonium sulfate and the like; drying the precipitated plasma to give powder thereof; and packing the powder with polyethylene packing material and treating gamma-ray.
Abstract:
PURPOSE: A manufacturing process for a low molecular weight of angiotensin converting enzyme(ACE) inhibitor from hot water extract of lettuce root is provided, which is an efficient and economical process. CONSTITUTION: The manufacturing process for a low molecular weight of ACE inhibitor from lettuce root comprises the steps of: removing an impurities by washing lettuce, separating its root, adding distilled water to the root, and extracting by making reflux for 2hrs at 100deg.C, 60deg.C; filtering, centrifuging for 30min. at 4deg.C, 8000rpm, and collecting the upper solution; ultra-filtering the upper solution using ultra-filter membrane(limit of M.W. is 1000) to prepare the extract; filtering through membrane filter paper, loading on high performance liquid chromatography, and separating a fraction, F4 with highest activity; and then gathering the F4, freeze-drying, and purifying using reversed phase HPLC.
Abstract:
PURPOSE: A manufacturing process for a low molecular weight of angiotensin converting enzyme(ACE) inhibitor from hot water extract of lettuce root is provided, which is an efficient and economical process. CONSTITUTION: The manufacturing process for a low molecular weight of ACE inhibitor from lettuce root comprises the steps of: removing an impurities by washing lettuce, separating its root, adding distilled water to the root, and extracting by making reflux for 2hrs at 100deg.C, 60deg.C; filtering, centrifuging for 30min. at 4deg.C, 8000rpm, and collecting the upper solution; ultra-filtering the upper solution using ultra-filter membrane(limit of M.W. is 1000) to prepare the extract; filtering through membrane filter paper, loading on high performance liquid chromatography, and separating a fraction, F4 with highest activity; and then gathering the F4, freeze-drying, and purifying using reversed phase HPLC.
Abstract:
PURPOSE: A process for preparing low molecular weight angiotensin converting enzyme(ACE) inhibitor from the extract of wild chrysanthemum is provided, thereby effectively and cheaply preparing the ACE inhibitor. CONSTITUTION: The process for preparing low molecular weight angiotensin converting enzyme(ACE) inhibitor from the extract of wild chrysanthemum comprises the steps of: washing wild chrysanthemum with water and extracting it using a reflux condenser at 100 deg.C for 2 hours; filtering and centrifuging at 4 deg.C and 8000 rpm for 30 minutes to obtain the supernatant; ultrafiltering the supernatant with molecular weight cut off(MWCO) of 1000 dalton to obtain a crude extract of wild chrysanthemum; and sequentially subjecting the crude extract of wild chrysanthemum to gel filtration chromatography, HPLC, ion exchange chromatography and reverse HPLC to obtain the low molecular weight angiotensin converting enzyme(ACE) inhibitor.